Flonase allergy relief and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Flonase allergy relief (fluticasone propionate), especially for people who are female, 50-59 old, also take Vitamin D3, and have Iridocyclitis.

The phase IV clinical study analyzes which people have Uveitis when taking Flonase allergy relief. It is created by eHealthMe based on reports of 9,502 people who have side effects when taking Flonase allergy relief from the FDA, and is updated regularly.

What is Flonase allergy relief?

Flonase allergy relief has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 9,599 Flonase allergy relief users. Check the latest studies of Flonase allergy relief.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 830 drugs and 1,529 conditions by eHealthMe. Check the latest studies of Uveitis.

On Jul, 27, 2026

9,502 people reported to have side effects when taking Flonase allergy relief.
Among them, 11 people (0.12%) have Uveitis.

Could Flonase allergy relief cause Uveitis?

Among these 11 people:

What is the gender of people who have Uveitis when taking Flonase allergy relief? *

female: 100 %
male: 0.0 %

What is the age of people who have Uveitis when taking Flonase allergy relief? *

What are other drugs people take besides Flonase allergy relief? *

What are other side effects people have besides Uveitis? *

Cellulitis (infection under the skin): 4 people, 36.36%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 18.18%
Migraine (headache): 2 people, 18.18%
Conjunctivitis (pink eye): 2 people, 18.18%
Drug Ineffective: 2 people, 18.18%
Feeling Abnormal: 2 people, 18.18%
Fever: 2 people, 18.18%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 18.18%
Injection Site Pain: 2 people, 18.18%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 18.18%

What are the existing conditions these people have? *

Scleritis (inflammation of sclera): 4 people, 36.36%
Iridocyclitis (inflammation of the iris and ciliary body of the eye): 4 people, 36.36%
Seasonal Allergy (allergic condition due to certain season): 2 people, 18.18%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 18.18%
Immunodeficiency Common Variable: 2 people, 18.18%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 18.18%
Asthma: 2 people, 18.18%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%
Migraine (headache): 1 person, 9.09%
Drowsiness: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase allergy relief and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flonase allergy relief:

Flonase allergy relief (9,599 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Flonase allergy relief:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (830 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,529 conditions)

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate (the active ingredients of Flonase allergy relief) and Flonase allergy relief (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.